HEADER OXIDOREDUCTASE 09-JUN-25 9VE2 TITLE CRYSTAL STRUCTURE OF HUMAN PEROXIREDOXIN I IN COMPLEX WITH FLUVASTATIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXIREDOXIN-1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NATURAL KILLER CELL-ENHANCING FACTOR A,NKEF-A,PROLIFERATION- COMPND 5 ASSOCIATED GENE PROTEIN,PAG,THIOREDOXIN PEROXIDASE 2,THIOREDOXIN- COMPND 6 DEPENDENT PEROXIDE REDUCTASE 2,THIOREDOXIN-DEPENDENT PEROXIREDOXIN 1; COMPND 7 EC: 1.11.1.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRDX1, PAGA, PAGB, TDPX2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS PRDX1, COMPLEX, FLUVASTATIN, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR H.ZHANG,H.XU REVDAT 1 17-JUN-26 9VE2 0 JRNL AUTH H.ZHANG,H.XU JRNL TITL FLUVASTATIN PROTECTS LEYDIG CELLS IN ORCHITIS THROUGH DIRECT JRNL TITL 2 ACTIVATION OF PEROXIREDOXIN 1 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15.2_3472 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.59 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 39018 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.157 REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.192 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 1926 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.5900 - 4.3400 0.99 2811 144 0.1467 0.1539 REMARK 3 2 4.3400 - 3.4400 1.00 2727 124 0.1293 0.1597 REMARK 3 3 3.4400 - 3.0100 1.00 2684 140 0.1515 0.1977 REMARK 3 4 3.0100 - 2.7300 0.99 2623 153 0.1616 0.1929 REMARK 3 5 2.7300 - 2.5400 0.99 2627 143 0.1751 0.2261 REMARK 3 6 2.5400 - 2.3900 1.00 2629 163 0.1572 0.2013 REMARK 3 7 2.3900 - 2.2700 1.00 2636 123 0.1591 0.2032 REMARK 3 8 2.2700 - 2.1700 1.00 2606 147 0.1620 0.2026 REMARK 3 9 2.1700 - 2.0900 1.00 2652 129 0.1564 0.1929 REMARK 3 10 2.0900 - 2.0100 1.00 2624 142 0.1546 0.2053 REMARK 3 11 2.0100 - 1.9500 1.00 2627 126 0.1576 0.2155 REMARK 3 12 1.9500 - 1.8900 0.99 2620 129 0.1789 0.2227 REMARK 3 13 1.8900 - 1.8400 1.00 2621 137 0.1702 0.2197 REMARK 3 14 1.8400 - 1.8000 1.00 2605 126 0.1931 0.2356 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.182 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.744 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2735 REMARK 3 ANGLE : 0.846 3703 REMARK 3 CHIRALITY : 0.061 401 REMARK 3 PLANARITY : 0.007 481 REMARK 3 DIHEDRAL : 10.849 1610 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9VE2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 13-JUN-25. REMARK 100 THE DEPOSITION ID IS D_1300060502. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9785 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39083 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 42.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 13.20 REMARK 200 R MERGE (I) : 0.08628 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 30.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M CALCIUM ACETATE 0.1 M CACODYLATE REMARK 280 PH 6.5 18% PEG 8000, AS 10% V/V TACSIMATE PH 7.5, 0.1M MES PH REMARK 280 6.5, AND 25% PEG3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.41650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.90150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.04850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.90150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.41650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.04850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 GLU A 171 REMARK 465 VAL A 172 REMARK 465 CYS A 173 REMARK 465 PRO A 174 REMARK 465 ALA A 175 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 GLU B 171 REMARK 465 VAL B 172 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 79 O HOH A 201 2.13 REMARK 500 O HOH A 292 O HOH A 372 2.13 REMARK 500 O HOH A 312 O HOH A 390 2.15 REMARK 500 NZ LYS B 68 O HOH B 301 2.15 REMARK 500 O HOH A 327 O HOH A 390 2.16 REMARK 500 O HOH A 367 O HOH A 373 2.16 REMARK 500 O HOH B 487 O HOH B 508 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 436 O HOH B 450 2565 2.10 REMARK 500 O HOH A 373 O HOH B 443 2565 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 465 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH B 519 DISTANCE = 6.22 ANGSTROMS DBREF 9VE2 A 1 175 UNP Q06830 PRDX1_HUMAN 1 175 DBREF 9VE2 B 1 175 UNP Q06830 PRDX1_HUMAN 1 175 SEQADV 9VE2 SER A 52 UNP Q06830 CYS 52 ENGINEERED MUTATION SEQADV 9VE2 SER A 83 UNP Q06830 CYS 83 ENGINEERED MUTATION SEQADV 9VE2 SER B 52 UNP Q06830 CYS 52 ENGINEERED MUTATION SEQADV 9VE2 SER B 83 UNP Q06830 CYS 83 ENGINEERED MUTATION SEQRES 1 A 175 MET SER SER GLY ASN ALA LYS ILE GLY HIS PRO ALA PRO SEQRES 2 A 175 ASN PHE LYS ALA THR ALA VAL MET PRO ASP GLY GLN PHE SEQRES 3 A 175 LYS ASP ILE SER LEU SER ASP TYR LYS GLY LYS TYR VAL SEQRES 4 A 175 VAL PHE PHE PHE TYR PRO LEU ASP PHE THR PHE VAL SER SEQRES 5 A 175 PRO THR GLU ILE ILE ALA PHE SER ASP ARG ALA GLU GLU SEQRES 6 A 175 PHE LYS LYS LEU ASN CYS GLN VAL ILE GLY ALA SER VAL SEQRES 7 A 175 ASP SER HIS PHE SER HIS LEU ALA TRP VAL ASN THR PRO SEQRES 8 A 175 LYS LYS GLN GLY GLY LEU GLY PRO MET ASN ILE PRO LEU SEQRES 9 A 175 VAL SER ASP PRO LYS ARG THR ILE ALA GLN ASP TYR GLY SEQRES 10 A 175 VAL LEU LYS ALA ASP GLU GLY ILE SER PHE ARG GLY LEU SEQRES 11 A 175 PHE ILE ILE ASP ASP LYS GLY ILE LEU ARG GLN ILE THR SEQRES 12 A 175 VAL ASN ASP LEU PRO VAL GLY ARG SER VAL ASP GLU THR SEQRES 13 A 175 LEU ARG LEU VAL GLN ALA PHE GLN PHE THR ASP LYS HIS SEQRES 14 A 175 GLY GLU VAL CYS PRO ALA SEQRES 1 B 175 MET SER SER GLY ASN ALA LYS ILE GLY HIS PRO ALA PRO SEQRES 2 B 175 ASN PHE LYS ALA THR ALA VAL MET PRO ASP GLY GLN PHE SEQRES 3 B 175 LYS ASP ILE SER LEU SER ASP TYR LYS GLY LYS TYR VAL SEQRES 4 B 175 VAL PHE PHE PHE TYR PRO LEU ASP PHE THR PHE VAL SER SEQRES 5 B 175 PRO THR GLU ILE ILE ALA PHE SER ASP ARG ALA GLU GLU SEQRES 6 B 175 PHE LYS LYS LEU ASN CYS GLN VAL ILE GLY ALA SER VAL SEQRES 7 B 175 ASP SER HIS PHE SER HIS LEU ALA TRP VAL ASN THR PRO SEQRES 8 B 175 LYS LYS GLN GLY GLY LEU GLY PRO MET ASN ILE PRO LEU SEQRES 9 B 175 VAL SER ASP PRO LYS ARG THR ILE ALA GLN ASP TYR GLY SEQRES 10 B 175 VAL LEU LYS ALA ASP GLU GLY ILE SER PHE ARG GLY LEU SEQRES 11 B 175 PHE ILE ILE ASP ASP LYS GLY ILE LEU ARG GLN ILE THR SEQRES 12 B 175 VAL ASN ASP LEU PRO VAL GLY ARG SER VAL ASP GLU THR SEQRES 13 B 175 LEU ARG LEU VAL GLN ALA PHE GLN PHE THR ASP LYS HIS SEQRES 14 B 175 GLY GLU VAL CYS PRO ALA HET 115 B 201 30 HETNAM 115 (3R,5S,6E)-7-[3-(4-FLUOROPHENYL)-1-(PROPAN-2-YL)-1H- HETNAM 2 115 INDOL-2-YL]-3,5-DIHYDROXYHEPT-6-ENOIC ACID HETSYN 115 FLUVASTATIN FORMUL 3 115 C24 H26 F N O4 FORMUL 4 HOH *484(H2 O) HELIX 1 AA1 SER A 32 LYS A 35 5 4 HELIX 2 AA2 VAL A 51 ARG A 62 1 12 HELIX 3 AA3 ARG A 62 LEU A 69 1 8 HELIX 4 AA4 SER A 80 THR A 90 1 11 HELIX 5 AA5 PRO A 91 GLY A 95 5 5 HELIX 6 AA6 ARG A 110 TYR A 116 1 7 HELIX 7 AA7 SER A 152 HIS A 169 1 18 HELIX 8 AA8 SER B 32 LYS B 35 5 4 HELIX 9 AA9 VAL B 51 ARG B 62 1 12 HELIX 10 AB1 ARG B 62 LYS B 68 1 7 HELIX 11 AB2 SER B 80 ASN B 89 1 10 HELIX 12 AB3 PRO B 91 GLY B 95 5 5 HELIX 13 AB4 ARG B 110 TYR B 116 1 7 HELIX 14 AB5 LYS B 120 GLY B 124 5 5 HELIX 15 AB6 SER B 152 ASP B 167 1 16 SHEET 1 AA114 PHE A 26 SER A 30 0 SHEET 2 AA114 LYS A 16 VAL A 20 -1 N ALA A 17 O ILE A 29 SHEET 3 AA114 LEU A 104 SER A 106 -1 O SER A 106 N THR A 18 SHEET 4 AA114 CYS A 71 SER A 77 1 N GLY A 75 O VAL A 105 SHEET 5 AA114 TYR A 38 PHE A 43 1 N PHE A 42 O ILE A 74 SHEET 6 AA114 ARG A 128 ILE A 133 -1 O GLY A 129 N PHE A 43 SHEET 7 AA114 LEU A 139 ASN A 145 -1 O ARG A 140 N ILE A 132 SHEET 8 AA114 LEU B 139 ASN B 145 -1 O VAL B 144 N ILE A 142 SHEET 9 AA114 ARG B 128 ILE B 133 -1 N ILE B 132 O ARG B 140 SHEET 10 AA114 TYR B 38 PHE B 43 -1 N PHE B 43 O GLY B 129 SHEET 11 AA114 CYS B 71 SER B 77 1 O ILE B 74 N VAL B 40 SHEET 12 AA114 LEU B 104 SER B 106 1 O VAL B 105 N GLY B 75 SHEET 13 AA114 LYS B 16 VAL B 20 -1 N THR B 18 O SER B 106 SHEET 14 AA114 PHE B 26 SER B 30 -1 O LYS B 27 N ALA B 19 CRYST1 64.833 78.097 81.803 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015424 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012805 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012224 0.00000 CONECT 2640 2641 2645 2646 CONECT 2641 2640 2642 2648 CONECT 2642 2641 2643 CONECT 2643 2642 2644 CONECT 2644 2643 2645 CONECT 2645 2640 2644 CONECT 2646 2640 2647 2651 CONECT 2647 2646 2648 2665 CONECT 2648 2641 2647 2666 CONECT 2649 2650 2654 CONECT 2650 2649 2651 CONECT 2651 2646 2650 2652 CONECT 2652 2651 2653 CONECT 2653 2652 2654 CONECT 2654 2649 2653 2655 CONECT 2655 2654 CONECT 2656 2659 CONECT 2657 2659 CONECT 2658 2661 CONECT 2659 2656 2657 2660 CONECT 2660 2659 2661 CONECT 2661 2658 2660 2662 CONECT 2662 2661 2663 CONECT 2663 2662 2664 2669 CONECT 2664 2663 2665 CONECT 2665 2647 2664 CONECT 2666 2648 2667 2668 CONECT 2667 2666 CONECT 2668 2666 CONECT 2669 2663 MASTER 277 0 1 15 14 0 0 6 3151 2 30 28 END